Clinical Trials Browser

Terminated × glembatumumab vedotin × Clear all

NCT02302339 2019-09-06

A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma

Phase 2 Terminated

132 enrolled 16 charts

Melanoma, Skin Neoplasms

NCT02713828 2019-07-16

PrE0504

Phase 1/2 Terminated

13 enrolled 12 charts

Squamous Cell Carcinoma of the Lung